Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ganglioneuroblastoma”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Early research (Phase 1)Study completedNCT01175356
What this trial is testing

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 99
Not applicableStudy completedNCT00904241
What this trial is testing

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 10,000
Not applicableLooking for participantsNCT03088020
What this trial is testing

International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE

Who this might be right for
Congenital Central Hypoventilation Syndrome
Ilya Khaytin 1,000
Large-scale testing (Phase 3)Looking for participantsNCT07375563
What this trial is testing

Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma

Who this might be right for
Neuroblastoma (NB)Ganglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 5
Early research (Phase 1)Active Not RecruitingNCT02311621
What this trial is testing

Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01

Who this might be right for
NeuroblastomaGanglioneuroblastoma
Seattle Children's Hospital 65
Not applicableActive Not RecruitingNCT02112617
What this trial is testing

Phase II Study of Proton Radiation Therapy for Neuroblastoma

Who this might be right for
NeuroblastomaGanglioneuroblastoma
Massachusetts General Hospital 30
Very early researchActive Not RecruitingNCT04040088
What this trial is testing

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

Who this might be right for
GanglioneuroblastomaGanglioneuromaNeuroblastoma
Mayo Clinic 20
Testing effectiveness (Phase 2)Looking for participantsNCT07502287
What this trial is testing

Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaHigh-Risk Neuroblastoma+1 more
Beijing Biotech 36
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Not applicableLooking for participantsNCT06296732
What this trial is testing

Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification

Who this might be right for
NeuroblastomaGanglioneuromaGanglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04385277
What this trial is testing

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

Who this might be right for
Ganglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 41
Large-scale testing (Phase 3)Looking for participantsNCT03126916
What this trial is testing

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Who this might be right for
GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 750
Testing effectiveness (Phase 2)Study completedNCT02095132
What this trial is testing

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Central Nervous System Embryonal Tumor With Rhabdoid FeaturesCentral Nervous System Embryonal Tumor, Not Otherwise SpecifiedCentral Nervous System Ganglioneuroblastoma+12 more
National Cancer Institute (NCI) 76
Testing effectiveness (Phase 2)Study completedNCT01767194
What this trial is testing

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Who this might be right for
GanglioneuroblastomaRecurrent Neuroblastoma
National Cancer Institute (NCI) 73
Not applicableNot Yet RecruitingNCT06798532
What this trial is testing

Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

Who this might be right for
Tumor, SolidNeuroblastic TumorsNeuroblastoma
Assistance Publique - Hôpitaux de Paris 150
Large-scale testing (Phase 3)Looking for participantsNCT06172296
What this trial is testing

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Who this might be right for
Ganglioneuroblastoma, NodularNeuroblastoma
National Cancer Institute (NCI) 478
Large-scale testing (Phase 3)Looking for participantsNCT06071897
What this trial is testing

Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma

Who this might be right for
NeuroblastomaGanglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Testing effectiveness (Phase 2)WithdrawnNCT06858501
What this trial is testing

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaGanglioneuroblastoma, NodularHigh Risk Neuroblastoma
Children's Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT02176967
What this trial is testing

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+1 more
Children's Oncology Group 621
Testing effectiveness (Phase 2)Study completedNCT03786783
What this trial is testing

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaHigh Risk Neuroblastoma
National Cancer Institute (NCI) 42
Next Page